SIRT2 and breast carcinoma: Compound 12a raised α‐tubulin acetylation levels in HeLa (Western blot80 and immunofluorescence314) and breast cancer MCF‐7 cells (immunofluorescence),313 consistent with SIRT2 inhibition, however, no further target engagement experiments were performed.